0000950170-24-026672.txt : 20240305
0000950170-24-026672.hdr.sgml : 20240305
20240305202334
ACCESSION NUMBER: 0000950170-24-026672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn Howard
CENTRAL INDEX KEY: 0001786335
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 24723928
MAIL ADDRESS:
STREET 1: C/O VIR BIOTECHNOLOGY, INC.
STREET 2: 499 ILLINOIS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
ownership.xml
4
X0508
4
2024-03-01
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001786335
Horn Howard
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
false
true
false
false
Chief Financial Officer
false
Common Stock
2024-03-01
4
A
false
19400
0
A
99766
D
Stock Option (Right to Buy)
53.69
2024-03-01
4
A
false
34200
0
A
2034-03-01
Common Stock
34200
34200
D
Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. The amount of securities beneficially owned in column 5 reflects the correction of a typographical error in the Form 4 filed by the Reporting Person on October 10, 2023 (the "October 2023 Form 4"). The accurate number of securities beneficially owned by the Reporting Person in Column 5 of the October 2023 Form 4 is 80,366.
On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
/s/ Karah Parschauer, attorney-in-fact
2024-03-05